bluebird bio IncNASDAQ:BLUENASDAQ FSI:E. Delinquent (Issuer missed regulatory filing deadline)
- LAST PRICE1.0600
- TODAY'S CHANGE (%)-0.0600 (-5.3571%)
- Bid / Lots1.0300/ 117
- Ask / Lots1.0800/ 245
- Open / Previous Close1.1400 / 1.1200
- Day Range
- 52 Week Range
- Volume6,870,207
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BLUE |
|---|---|---|
| 09:32 ET | 94980 | 1.14 |
| 09:34 ET | 48859 | 1.11 |
| 09:36 ET | 82425 | 1.09 |
| 09:38 ET | 77545 | 1.09 |
| 09:39 ET | 48638 | 1.0875 |
| 09:41 ET | 72862 | 1.0784 |
| 09:43 ET | 312072 | 1.06 |
| 09:45 ET | 238066 | 1.04 |
| 09:48 ET | 121339 | 1.045 |
| 09:50 ET | 55212 | 1.045 |
| 09:52 ET | 83670 | 1.045 |
| 09:54 ET | 28909 | 1.049 |
| 09:56 ET | 59565 | 1.045 |
| 09:57 ET | 171756 | 1.06 |
| 09:59 ET | 67002 | 1.05 |
| 10:01 ET | 146679 | 1.04 |
| 10:03 ET | 166517 | 1.05 |
| 10:06 ET | 116612 | 1.05 |
| 10:08 ET | 38938 | 1.05 |
| 10:10 ET | 29820 | 1.055 |
| 10:12 ET | 14737 | 1.05 |
| 10:14 ET | 17613 | 1.05 |
| 10:15 ET | 15526 | 1.05 |
| 10:17 ET | 9330 | 1.055 |
| 10:19 ET | 16955 | 1.055 |
| 10:21 ET | 17682 | 1.05 |
| 10:24 ET | 17698 | 1.05 |
| 10:26 ET | 112789 | 1.04 |
| 10:28 ET | 50519 | 1.04 |
| 10:30 ET | 347174 | 1.045 |
| 10:32 ET | 76918 | 1.05 |
| 10:33 ET | 25005 | 1.05 |
| 10:35 ET | 20801 | 1.05 |
| 10:37 ET | 31181 | 1.05 |
| 10:39 ET | 18150 | 1.055 |
| 10:42 ET | 26354 | 1.05 |
| 10:44 ET | 16804 | 1.05 |
| 10:46 ET | 11300 | 1.05 |
| 10:48 ET | 11859 | 1.05 |
| 10:50 ET | 24438 | 1.055 |
| 10:51 ET | 8934 | 1.05 |
| 10:53 ET | 6377 | 1.05 |
| 10:55 ET | 28009 | 1.055 |
| 10:57 ET | 6949 | 1.05 |
| 11:00 ET | 7211 | 1.05 |
| 11:02 ET | 36136 | 1.055 |
| 11:04 ET | 9025 | 1.055 |
| 11:06 ET | 13958 | 1.055 |
| 11:08 ET | 18187 | 1.05 |
| 11:09 ET | 11618 | 1.05 |
| 11:11 ET | 15708 | 1.05 |
| 11:13 ET | 49720 | 1.055 |
| 11:15 ET | 7761 | 1.055 |
| 11:18 ET | 8411 | 1.05 |
| 11:20 ET | 18936 | 1.05 |
| 11:22 ET | 9677 | 1.05 |
| 11:24 ET | 7050 | 1.05 |
| 11:26 ET | 2500 | 1.05 |
| 11:27 ET | 3670 | 1.05 |
| 11:29 ET | 6321 | 1.055 |
| 11:31 ET | 5366 | 1.05 |
| 11:33 ET | 9012 | 1.05 |
| 11:36 ET | 7369 | 1.055 |
| 11:38 ET | 12586 | 1.05 |
| 11:40 ET | 4399 | 1.055 |
| 11:42 ET | 3029 | 1.05 |
| 11:44 ET | 6147 | 1.055 |
| 11:45 ET | 11592 | 1.05 |
| 11:47 ET | 10823 | 1.05 |
| 11:49 ET | 11297 | 1.05 |
| 11:51 ET | 198678 | 1.035 |
| 11:54 ET | 33132 | 1.0375 |
| 11:56 ET | 12533 | 1.035 |
| 11:58 ET | 151874 | 1.035 |
| 12:00 ET | 27200 | 1.035 |
| 12:02 ET | 29557 | 1.045 |
| 12:03 ET | 25356 | 1.045 |
| 12:05 ET | 16550 | 1.04 |
| 12:07 ET | 7120 | 1.04 |
| 12:09 ET | 18901 | 1.04 |
| 12:12 ET | 7161 | 1.045 |
| 12:14 ET | 23620 | 1.045 |
| 12:16 ET | 13702 | 1.04 |
| 12:18 ET | 37814 | 1.03 |
| 12:20 ET | 44722 | 1.04 |
| 12:21 ET | 8971 | 1.045 |
| 12:23 ET | 2850 | 1.04 |
| 12:25 ET | 79365 | 1.04 |
| 12:27 ET | 142873 | 1.06 |
| 12:30 ET | 54684 | 1.05 |
| 12:32 ET | 6208 | 1.05 |
| 12:34 ET | 18334 | 1.055 |
| 12:36 ET | 42737 | 1.045 |
| 12:38 ET | 3346 | 1.045 |
| 12:39 ET | 10875 | 1.045 |
| 12:41 ET | 16654 | 1.04 |
| 12:43 ET | 5744 | 1.045 |
| 12:45 ET | 30400 | 1.055 |
| 12:48 ET | 1318 | 1.055 |
| 12:50 ET | 3800 | 1.055 |
| 12:52 ET | 4483 | 1.0599 |
| 12:54 ET | 8048 | 1.05 |
| 12:56 ET | 6100 | 1.055 |
| 12:57 ET | 3932 | 1.055 |
| 12:59 ET | 12997 | 1.055 |
| 01:01 ET | 17238 | 1.05 |
| 01:03 ET | 3200 | 1.055 |
| 01:06 ET | 2200 | 1.055 |
| 01:08 ET | 63202 | 1.055 |
| 01:10 ET | 3742 | 1.055 |
| 01:12 ET | 37974 | 1.055 |
| 01:14 ET | 4200 | 1.05 |
| 01:15 ET | 2465 | 1.05 |
| 01:17 ET | 2900 | 1.055 |
| 01:19 ET | 2700 | 1.05 |
| 01:21 ET | 34427 | 1.045 |
| 01:24 ET | 7549 | 1.0401 |
| 01:26 ET | 353845 | 1.04 |
| 01:28 ET | 61632 | 1.045 |
| 01:30 ET | 5777 | 1.04 |
| 01:32 ET | 6055 | 1.04 |
| 01:33 ET | 2509 | 1.04 |
| 01:35 ET | 1600 | 1.04 |
| 01:37 ET | 3396 | 1.04 |
| 01:39 ET | 2500 | 1.045 |
| 01:42 ET | 1967 | 1.0402 |
| 01:44 ET | 11516 | 1.045 |
| 01:46 ET | 1350 | 1.04 |
| 01:48 ET | 1761 | 1.04 |
| 01:50 ET | 147515 | 1.0301 |
| 01:51 ET | 15957 | 1.035 |
| 01:53 ET | 800 | 1.03 |
| 01:55 ET | 4180 | 1.035 |
| 01:57 ET | 28979 | 1.035 |
| 02:00 ET | 4400 | 1.035 |
| 02:02 ET | 13971 | 1.035 |
| 02:04 ET | 21438 | 1.0301 |
| 02:06 ET | 4028 | 1.035 |
| 02:08 ET | 10841 | 1.035 |
| 02:09 ET | 21166 | 1.03 |
| 02:11 ET | 3368 | 1.035 |
| 02:13 ET | 95791 | 1.035 |
| 02:15 ET | 11880 | 1.0399 |
| 02:18 ET | 6578 | 1.0393 |
| 02:20 ET | 2100 | 1.035 |
| 02:22 ET | 6919 | 1.035 |
| 02:24 ET | 1580 | 1.035 |
| 02:26 ET | 34088 | 1.035 |
| 02:27 ET | 782 | 1.04 |
| 02:29 ET | 28658 | 1.035 |
| 02:31 ET | 636 | 1.04 |
| 02:33 ET | 4051 | 1.035 |
| 02:36 ET | 1106 | 1.04 |
| 02:38 ET | 921 | 1.035 |
| 02:40 ET | 1943 | 1.035 |
| 02:42 ET | 4694 | 1.035 |
| 02:44 ET | 700 | 1.0395 |
| 02:45 ET | 1100 | 1.035 |
| 02:47 ET | 1816 | 1.03 |
| 02:49 ET | 1000 | 1.035 |
| 02:51 ET | 1048 | 1.035 |
| 02:54 ET | 4919 | 1.0384 |
| 02:56 ET | 1900 | 1.035 |
| 02:58 ET | 48997 | 1.0215 |
| 03:00 ET | 3315 | 1.025 |
| 03:02 ET | 508 | 1.025 |
| 03:03 ET | 600 | 1.02 |
| 03:05 ET | 3700 | 1.025 |
| 03:07 ET | 4950 | 1.025 |
| 03:09 ET | 4860 | 1.025 |
| 03:12 ET | 3234 | 1.025 |
| 03:14 ET | 1900 | 1.025 |
| 03:16 ET | 83956 | 1.025 |
| 03:18 ET | 1744 | 1.025 |
| 03:20 ET | 8750 | 1.025 |
| 03:21 ET | 15818 | 1.025 |
| 03:23 ET | 7829 | 1.02 |
| 03:25 ET | 1675 | 1.03 |
| 03:27 ET | 2374 | 1.025 |
| 03:30 ET | 2700 | 1.025 |
| 03:32 ET | 6849 | 1.02 |
| 03:34 ET | 21176 | 1.025 |
| 03:36 ET | 48986 | 1.035 |
| 03:38 ET | 12097 | 1.04 |
| 03:39 ET | 18154 | 1.04 |
| 03:41 ET | 10907 | 1.0325 |
| 03:43 ET | 8357 | 1.035 |
| 03:45 ET | 6900 | 1.035 |
| 03:48 ET | 44006 | 1.035 |
| 03:50 ET | 12031 | 1.035 |
| 03:52 ET | 63945 | 1.045 |
| 03:54 ET | 36758 | 1.055 |
| 03:56 ET | 56858 | 1.055 |
| 03:57 ET | 88090 | 1.06 |
| 03:59 ET | 144832 | 1.06 |
Yesterday
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE, from 23 hours ago by Dow Jones
23 hours ago by Dow Jonesbluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BLUE, from 2:47PM ET on Friday May 10, 2024 by Dow Jones
2:47PM ET on Friday May 10, 2024 by Dow Jonesbluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights - BLUE, from 2:47PM ET on Friday May 10, 2024 by Dow Jones
2:47PM ET on Friday May 10, 2024 by Dow JonesGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE), from 1:41PM ET on Friday May 10, 2024 by Dow Jones
1:41PM ET on Friday May 10, 2024 by Dow Jonesbluebird bio, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights - BLUE, from 1:17PM ET on Friday May 10, 2024 by Dow Jones
1:17PM ET on Friday May 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
bluebird bio Inc | 201.8M | -1.4x | --- |
Adverum Biotechnologies Inc | 193.0M | -0.8x | --- |
Generation Bio Co | 198.8M | -1.5x | --- |
Acumen Pharmaceuticals Inc | 201.9M | -3.1x | --- |
CervoMed Inc | 203.5M | -39.3x | --- |
Omeros Corp | 203.4M | -1.3x | --- |
Company Information
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. It has two gene therapies: ZYNTEGLO (betibeglogene autotemcel) and SKYSONA (elivaldogene autotemcel). ZYNTEGLO is the first gene therapy for people with B-thalassemia who require regular red blood cell transfusions. SKYSONA (elivaldogene autotemcel), also known as eli-cel, is used to slow the progression of eurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). It is also developing (lovotibeglogene autotemcel), also known as lovo-cel, as a one-time treatment for patients with sickle cell disease (SCD).
Contact Information
- Headquarters
- 455 Grand Union BoulevardSOMERVILLE, MA, United States 02145
- Phone
- 339-499-9300
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Mark Vachon
- President, Chief Executive Officer, Director
- Andrew Obenshain
- Chief Financial Officer
- Christopher Krawtschuk
- Chief Commercial and Operating Officer
- Thomas Klima
- Chief Medical Officer
- Richard Colvin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $201.8M |
|---|---|
Revenue (TTM) | $21.7M |
Shares Outstanding | 190.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.85 |
EPS | $-0.74 |
Book Value | $2.37 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 9.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -626.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
